Cargando…
Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers
PURPOSE: To report on a case of a young female with progressing dry eye symptoms and evolving autoimmune markers consistent with a presentation of early Sjogren's syndrome (SS). OBSERVATIONS: A 32 year-old female presented with chronic dry eye symptoms refractory to artificial tears. Slit lamp...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731714/ https://www.ncbi.nlm.nih.gov/pubmed/29260117 http://dx.doi.org/10.1016/j.ajoc.2017.10.008 |
_version_ | 1783286553241452544 |
---|---|
author | Phung, Lam Lollett, Ivonne V. Goldhardt, Raquel Davis, Janet L. Young, Larry Ascherman, Dana Galor, Anat |
author_facet | Phung, Lam Lollett, Ivonne V. Goldhardt, Raquel Davis, Janet L. Young, Larry Ascherman, Dana Galor, Anat |
author_sort | Phung, Lam |
collection | PubMed |
description | PURPOSE: To report on a case of a young female with progressing dry eye symptoms and evolving autoimmune markers consistent with a presentation of early Sjogren's syndrome (SS). OBSERVATIONS: A 32 year-old female presented with chronic dry eye symptoms refractory to artificial tears. Slit lamp examination revealed punctate epithelial erosions, decreased tear break-up time, and decreased tear lake bilaterally. Initial tests for ocular surface inflammation (InflammaDry, Quidel, San Diego) and systemic autoantibodies (antinuclear antibodies, anti-SSA/Ro and anti-SSB/La) were negative. After 4 months of persistent ocular symptoms and signs, ocular surface inflammation was detected via InflammaDry and blood results included a positive antinuclear antibody (1:160), rheumatoid factor (IgG 25.3 EU/ml), and carbonic anhydrase 6 (IgM 20.2 EU/ml), but persistently negative anti-SSA/Ro and anti-SSB/La antibodies. CONCLUSIONS AND IMPORTANCE: Taken together, these findings were suggestive of early Sjogren's syndrome with simultaneous appearance of both ocular and serum biomarkers. Novel autoantibodies testing in suspected patients can guide early intervention and potentially improve both the glandular and extra-glandular function in patients. |
format | Online Article Text |
id | pubmed-5731714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-57317142017-12-19 Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers Phung, Lam Lollett, Ivonne V. Goldhardt, Raquel Davis, Janet L. Young, Larry Ascherman, Dana Galor, Anat Am J Ophthalmol Case Rep Case report PURPOSE: To report on a case of a young female with progressing dry eye symptoms and evolving autoimmune markers consistent with a presentation of early Sjogren's syndrome (SS). OBSERVATIONS: A 32 year-old female presented with chronic dry eye symptoms refractory to artificial tears. Slit lamp examination revealed punctate epithelial erosions, decreased tear break-up time, and decreased tear lake bilaterally. Initial tests for ocular surface inflammation (InflammaDry, Quidel, San Diego) and systemic autoantibodies (antinuclear antibodies, anti-SSA/Ro and anti-SSB/La) were negative. After 4 months of persistent ocular symptoms and signs, ocular surface inflammation was detected via InflammaDry and blood results included a positive antinuclear antibody (1:160), rheumatoid factor (IgG 25.3 EU/ml), and carbonic anhydrase 6 (IgM 20.2 EU/ml), but persistently negative anti-SSA/Ro and anti-SSB/La antibodies. CONCLUSIONS AND IMPORTANCE: Taken together, these findings were suggestive of early Sjogren's syndrome with simultaneous appearance of both ocular and serum biomarkers. Novel autoantibodies testing in suspected patients can guide early intervention and potentially improve both the glandular and extra-glandular function in patients. Elsevier 2017-10-06 /pmc/articles/PMC5731714/ /pubmed/29260117 http://dx.doi.org/10.1016/j.ajoc.2017.10.008 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case report Phung, Lam Lollett, Ivonne V. Goldhardt, Raquel Davis, Janet L. Young, Larry Ascherman, Dana Galor, Anat Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers |
title | Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers |
title_full | Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers |
title_fullStr | Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers |
title_full_unstemmed | Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers |
title_short | Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers |
title_sort | parallel ocular and serologic course in a patient with early sjogren's syndrome markers |
topic | Case report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731714/ https://www.ncbi.nlm.nih.gov/pubmed/29260117 http://dx.doi.org/10.1016/j.ajoc.2017.10.008 |
work_keys_str_mv | AT phunglam parallelocularandserologiccourseinapatientwithearlysjogrenssyndromemarkers AT lollettivonnev parallelocularandserologiccourseinapatientwithearlysjogrenssyndromemarkers AT goldhardtraquel parallelocularandserologiccourseinapatientwithearlysjogrenssyndromemarkers AT davisjanetl parallelocularandserologiccourseinapatientwithearlysjogrenssyndromemarkers AT younglarry parallelocularandserologiccourseinapatientwithearlysjogrenssyndromemarkers AT aschermandana parallelocularandserologiccourseinapatientwithearlysjogrenssyndromemarkers AT galoranat parallelocularandserologiccourseinapatientwithearlysjogrenssyndromemarkers |